Rationale and desiǵn for the PAINT randomized trial;Fundamento e desenho do teste randomizado PAINT

Arquivos Brasileiros de Cardiologia

Volumn 93, Issue 6, 2009, Pages

  Lemos, Pedro A ^a   Moulin, Bruno ^b   Perin, Marco A ^c   Oliveira, Ludmilla A R R ^d   Arruda, J Airton ^e   Lima, Valter C ^f   Lima, Antonio A G ^g   Caramori, Paulo R A ^h   Medeiros, Cesar R ⁱ   Barbosa, Mauricio R ^j   Brito Jr , Fabio S ^k   Ribeiro, Expedito E ^a   Martinez, Eulogio E ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL TXAGORRITXU   (Spain)

^c HOSPITAL SANTA MARCELINA   (Brazil)

^d Natal Hospital Center   (Brazil)

^e Hospital Meridional   (Spain)

^f FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^g Walter Cantídio Univ Hosp   (Brazil)

^h PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

ⁱ Rede d'Or de Hospitais   (Brazil)

^j Hospital Biocor   (Brazil)

^k Hospital São Camilo São Paulo   (Brazil)

more..

Author keywords

Coronary restenosis; Drug eluting stents; Multicenter study; Paclitaxel; Sirolimus

Indexed keywords

PACLITAXEL; POLYMER; RAPAMYCIN; CARDIOVASCULAR AGENT;

ADULT; ARTICLE; BARE METAL STENT; BRAZIL; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEATH; DRUG ELUTING STENT; HEART INFARCTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL; STENT THROMBOSIS; TREATMENT OUTCOME; ADOLESCENT; BIODEGRADABLE IMPLANT; CHEMISTRY; CORONARY ARTERY THROMBOSIS; EPIDEMIOLOGY; INSTRUMENTATION; METHODOLOGY; PATHOLOGY; PROSTHESIS; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

ABSORBABLE IMPLANTS; ADOLESCENT; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BRAZIL; CARDIOVASCULAR AGENTS; CORONARY DISEASE; CORONARY RESTENOSIS; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; EPIDEMIOLOGIC METHODS; HUMANS; PACLITAXEL; POLYMERS; PROSTHESIS DESIGN; SIROLIMUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77950996378     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Lemos PA, Mercado N, van Domburg RT, Kuntz RE, O'Neill WW, Serruys PW Comparison of late luminal loss response pattern after sirolimus-eluting stent implantation or conventional stenting. Circulation. 2004; 110: 3199-3205
2. Lemos PA, Serruys PW, van Domburg RT, Saia F, Arampatzis CA, Hoye A, et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation. 2004; 109: 190-195
3. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, et al. Safety and efficacy of sirolimus-and paclitaxel-eluting coronary stents. N Engl J Med. 2007; 356: 998-1008.
4. Spaulding C, Daemen J, Boersma E, Cutlip DE, Serruys PW. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med. 2007; 356: 989-997
5. Mauri L, Hsieh WH, Massaro JM, Ho KK, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med. 2007; 356: 1020-1029
6. Luepker RV, Apple FS, Christenson RH, Crow RS, Fortmann Sp, Goff D, et al. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation. 2003; 108: 2543-2549
7. Serruys PW, Daemen J. Are drug-eluting stents associated with a higher rate of late thrombosis than bare metal stents? Late stent thrombosis: a nuisance in both bare metal and drug-eluting stents. Circulation. 2007; 115: 1433-1439
8. Hsu J. Multiple comparisons: theory and methods. London: Chapman & Hall; 1996.
9. Di Mario C, Haase J, den Boer A, Reiber JH, Serruys PW. Edge detection versus densitometry in the quantitative assessment of stenosis phantoms: an in vivo comparison in porcine coronary arteries. Am Heart J. 1992; 124: 1181-1189
10. Haase J, Di Mario C, Slager CJ, van der Giessen WJ, den Boer A, de Feyter PJ, et al. In-vivo validation of on-line and off-line geometric coronary measurements using insertion of stenosis phantoms in porcine coronary arteries. Cathet Cardiovasc Diagn. 1992; 27: 16-27.
11. Haase J, Slager CJ, Keane D, Foley DP, den Boer A, Doriot PA, et al. Quantification of intracoronary volume by videodensitometry: validation study using fluid filling of human coronary casts. Cathet Cardiovasc Diagn. 1994; 33: 89-94.
12. Hausleiter J, Jost S, Nolte CW, Dirschinger J, Kastrati A, Stiel GM, et al. Comparative in-vitro validation of eight first-and second-generation quantitative coronary angiography systems. Coron Artery Dis. 1997; 8: 83-90.
13. Brito FS Jr, Rosa WC, Arruda JA, Tedesco H, Pestana JO, Lima VC. Efficacy and safety of oral sirolimus to inhibit in-stent intimal hyperplasia. Catheter Cardiovasc Interv. 2005; 64: 413-418
14. Lemos PA, Serruys PW, Sousa JE. Drug-eluting stents: cost versus clinical benefit. Circulation. 2003; 107: 3003-3007
15. Kastrati A, Mehilli J, von Beckerath N, Dibra A, Hausleiter J, Pache J, et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA. 2005; 293: 165-171
16. Goy JJ, Stauffer JC, Siegenthaler M, Benoit A, Seydoux C. A prospective randomized comparison between paclitaxel and sirolimus stents in the real world of interventional cardiology: the TAXi trial. J Am Coll Cardiol. 2005; 45: 308-311
17. Windecker S, Remondino A, Eberli FR, Juni P, Raber L, Wenaweser P, et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med. 2005; 353: 653-662 (Pubitemid 41175673)
18. Dibra A, Kastrati A, Mehilli J, Pache J, Schuhlen H, von Beckerath N, et al. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med. 2005; 353: 663-670
19. Kaiser C, Brunner-La Rocca HP, Buser PT, Bonetti PO, Osswald S, Linka A, et al. Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitats Trial (BASKET). Lancet. 2005; 366: 921-929
20. Mehilli J, Dibra A, Kastrati A, Pache J, Dirschinger J, Schomig A. Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels. Eur Heart J. 2006; 27: 260-266
21. Morice MC, Colombo A, Meier B, Serruys P, Tamburino C, Guagliumi G, et al. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial. JAMA. 2006; 295: 895-904.
22. Cervinka P, Costa MA, Angiolillo DJ, Spacek R, Bystron M, Kvasnak M, et al. Head-to-head comparison between sirolimus-eluting and paclitaxel-eluting stents in patients with complex coronary artery disease: an intravascular ultrasound study. Catheter Cardiovasc Interv. 2006; 67: 846-851
23. Kim YH, Park SW, Lee SW, Park DW, Yun SC, Lee CW, et al. Sirolimus-eluting stent versus paclitaxel-eluting stent for patients with long coronary artery disease. Circulation. 2006; 114: 2148-2153
24. Pan M, Suarez de Lezo J, Medina A, Romero M, Delgado A, Segura J, et al. Drug-eluting stents for the treatment of bifurcation lesions: a randomized comparison between paclitaxel and sirolimus stents. Am Heart J. 2007; 153: 15 e1-7.
25. Petronio AS, De Carlo M, Branchitta G, Papini B, Ciabatti N, Gistri R, et al. Randomized comparison of sirolimus and paclitaxel drug-eluting stents for long lesions in the left anterior descending artery: an intravascular ultrasound study. J Am Coll Cardiol. 2007; 49: 539-546
26. Wessely R, Kastrati A, Mehilli J, Dibra A, Pache J, Schomig A. Randomized trial of rapamycin- and paclitaxel-eluting stents with identical biodegradable polymeric coating and design. Eur Heart J. 2007; 28: 2720-2725
27. van Hout BA, Serruys PW, Lemos PA, van den Brand MJ, van Es GA, Lindeboom WK, et al. One year cost effectiveness of sirolimus eluting stents compared with bare metal stents in the treatment of single native de novo coronary lesions: an analysis from the RAVEL trial. Heart. 2005; 91: 507-512
28. Prineas RJ, Crow RS, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings. Littleton, MA: John Wright-PSG, Inc.; 1982.
29. Minnesota Uo. Minnesota ECG Coding Center. [Accessed March 7, 2005]. Available frrom: http://www.epi.umn.edu/ecg.